Mel Mann, MBA, M.Ed

20 yrs ago, I had terminal #Cancer with no cure in sight. Read about my miracle! curetoday.com/community/mel-… #Retweet

How Gleevec changed cancer treatment npr.org/transcripts/nx…

We’ve been gatekeeping long enough! 🔑 For more than 75 years, we’ve been committed to creating a world without blood cancer. While our mission hasn’t changed, today, our name does. 📣 📰 Headline this moment—go!👇

Forget Zodiac signs: we’re judging you based on your favorite clinical acronym. 🧬 Whether you’re an Exceptional Data Connoisseur or just an eCOA expert powered by caffeine, we see you. 👀 Which one are you? Celebrate Clinical Trials Day with us by sharing in the comments below! #CTD2026 #ClinicalTrialsDay #Medidata

Podcast: Experience as a patient in a first-in-human clinical trial clinicaltrialsarena.com/features/podca… via @TrialsArena

This drug changed cancer treatment – and medical research – forever : Short Wave npr.org/2026/05/11/nx-…

In 1998, @MelDMann was told he had #CML and that he had three years to live. Fast forward to 2026 ⏩ Mel's still healthy and training for his next marathon. 🏃 Listen (via @NPR): npr.org/2026/05/11/nx-…

Don’t Lose Hope! Support Clinical Research! linkedin.com/posts/meldmann…

In 1998, @MelDMann was told he had #CML and that he had three years to live. Fast forward to 2026 ⏩ Mel's still healthy and training for his next marathon. 🏃 Listen (via @NPR): npr.org/2026/05/11/nx-…

How a pill approved 25 years ago transformed cancer treatment | KGOU - Oklahoma's NPR Source - When the Food and Drug Administration approved Gleevec to treat a form of leukemia in 2001, it ushered in a new era in cancer care. - ift.tt/4wuHDhB

How Gleevec changed cancer treatment npr.org/2026/05/10/nx-…

How #Gleevec changed cancer treatment npr.org/2026/05/10/nx-…

I have been so impressed by the recent Daraxonrasib data that I forgot the 25 year anniversary of the precision medicine OG - STI571 (Gleevec). What a triumph of modern medicine. And congratulations to @MelDMann - still going strong all these years later! npr.org/2026/05/10/nx-…

慢性骨髄性白血病の治療薬「Imatinib」(米国内での商標名:Gleevec)が2001年にFDAに承認されてから This man was given three years to live … in 1998. He’s still here npr.org/2026/05/11/nx-…この5/10で丸25年という記念日だったとか…当時としては革新的画期的な薬だった…研究開発した人は凄いね